American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 30, Issue 3 , Pages 162-165 , May 2009

Otolaryngologic manifestations of mitochondrial cytopathies

  • Anita Jeyakumar, MD

      Affiliations

    • Department of Otolaryngology, Washington University, School of Medicine, St Louis, MO, USA
    • Corresponding Author InformationCorresponding author. Department of Otolaryngology, Washington University, School of Medicine, St Louis, MO 63130, USA. Tel.: +1 314 454 2136; fax: +1 314 454 2174.
    • ,
  • Mary E. Williamson, MD

      Affiliations

    • Department of Otolaryngology, The Cleveland Clinic Foundation, Cleveland, OH, USA
    • ,
  • Todd M. Brickman, MD, PhD

      Affiliations

    • Department of Otolaryngology, St. Louis University, St. Louis, MO, USA
    • ,
  • Paul Krakovitz, MD

      Affiliations

    • Department of Otolaryngology, The Cleveland Clinic Foundation, Cleveland, OH, USA
    • ,
  • Sumit Parikh, MD

      Affiliations

    • Center for Child Neurology, The Cleveland Clinic Foundation, Cleveland, OH, USA

Received 1 April 2008

References 

  1. Naviaux RK, McGowan KA. Organismal effects of mitochondrial dysfunction. Hum Reprod. 2000;15(Suppl 2):44–56
  2. Sanderson S, Green A, Preece MA, et al. The incidence of inherited metabolic disorders in the West Midlands, UK. Arch Dis Child. 2006;91(11):896–899
  3. Darin N, Oldfors A, Moslemi AR, et al. The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA abnormalities. Ann Neurol. 2001;49(3):377–383
  4. Skladal D, Halliday J, Thorburn DR. Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain. 2003;126(Pt 8):1905–1912
  5. Schaefer AM, Taylor RW, Turnbull DM, et al. The epidemiology of mitochondrial disorders—past, present and future. Biochim Biophys Acta. 2004;1659(2-3):115–120
  6. Castro-Gago M, Blanco-Barca MO, Campos-Gonzalez Y, et al. Epidemiology of pediatric mitochondrial respiratory chain disorders in northwest Spain. Pediatr Neurol. 2006;34(3):204–211
  7. Dimauro S, Davidzon G. Mitochondrial DNA and disease. Ann Med. 2005;37(3):222–232
  8. Hostoffer WR. The use of low dose intramuscular immunoglobulin for prophylaxis against recurrent respiratory tract infections and varicella infections in children with mitochondrial disorders. J Allergy Clin Immunol. 2006;117(2):S283
  9. Edmonds JL, Kirse DJ, Kearns D, et al. The otolaryngological manifestations of mitochondrial disease and the risk of neurodegeneration with infection. Arch Otolaryngol Head Neck Surg. 2002;128:355–362
  10. Hirano M, Kaufmann P, De Vivo DC, et al. In: Mitochondrial neurology. I: encephalopathies. Mitochondrial medicine. London: Informa Health care; 2006;p. 27–44
  11. Salvatore D, Hirano M, Schon EA. Approaches to the treatment of mitochondrial diseases. Muscle Nerve. 2006;34:265–283
  12. Lalani S, Vladutiu GD, Plunkett K, et al. Isolated mitochondrial myopathy-associated with muscle coenzyme Q10 deficiency. Arch Neurol. 2005;62:317–320
  13. Schon EA. Appendix. In:  DiMauro S,  Hirano M,  Schon EA editor. Mitochondrial medicine. London: Informa Health care; 2006;p. 329–335
  14. Ali NJ, Pitson DJ, Stradling JR. Snoring, sleep disturbance, and behaviour in 4–5 year olds. Arch Dis Child. 1993;68:360–366
  15. Gislason T, Benediktsdottir B. Snoring, apneic episodes, and nocturnal hypoxemia among children 6 months to 6 years old. Chest. 1995;107:963–966
  16. Redline S, Tishler PV, Schluchter M, et al. Risk factors for sleep-disordered breathing in children. Associations with obesity, race, and respiratory problems. Am J Respir Crit Care Med. 1999;159:1527–1532
  17. Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J. 2004;23(9):824–828

PII: S0196-0709(08)00074-4

doi: 10.1016/j.amjoto.2008.04.008

American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 30, Issue 3 , Pages 162-165 , May 2009

Article Tools